BioCryst Pharmaceuticals, Inc. (FRA:BO1)
Germany · Delayed Price · Currency is EUR 5.46
-0.11 (-1.97%)
Last updated: Jan 29, 2026, 8:08 AM CET
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of €1.37 billion as of January 30, 2026. Its market cap has decreased by -5.69% in one year.
Market Cap
1.37B
Enterprise Value
1.77B
Revenue
511.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.46
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 19.07M to 1.37B, an increase of 7,096.57%. That is a compound annual growth rate of 14.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.37B | -1.86% |
| Dec 31, 2025 | 1.40B | -7.03% |
| Dec 31, 2024 | 1.50B | 35.56% |
| Dec 29, 2023 | 1.11B | -44.58% |
| Dec 30, 2022 | 2.00B | -8.62% |
| Dec 31, 2021 | 2.19B | 103.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |